Alnylam® Pharmaceuticals
Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 68.662 |
| 2025-03 | 67.912 |
| 2025-04 | 61.73 |
| 2025-05 | 56.556 |
| Source | Traffic Share |
|---|---|
| search | 57.91% |
| direct | 33.24% |
| referrals | 5.96% |
| social | 2.43% |
| paid referrals | 0.34% |
| 0.07% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| alnylam | 1,931 | 19,310 | $5.08 |
| alnylam pharmaceuticals | 820 | 8,200 | $5.82 |
| alnylam pipeline | 123 | 1,230 | $3.69 |
| alnylam pharmaceuticals careers | 35 | 350 | $0.00 |
| alnylam ema | 5 | 50 | $0.00 |